April 26, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Frame Cancer Therapeutics, an Amsterdam pharmaceutical company, on a series of clinical proteomics projects.
Frame Therapeutics is dedicated to transforming the treatment of cancer by directing the immune systemtowards Frame neoantigens. Frame scientist team is developing personalized cancer immunotherapies, that are designed based on the Frame neoantigens uniquely encoded by the genome of each patient’s tumor.
Complete Omics is proud to work with Frame Therapeutics and our mutual efforts will help bring numerous personalized cancer therapeutic strategies to reality.
